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Abstract 
Background: After the decrease in clinical malaria incidence observed in Mozambique until 2009, a steady resur-
gence of cases per year has been reported nationally, reaching alarming levels in 2014. However, little is known about 
the clinical profile of the cases presented, or the possible epidemiological factors contributing to the resurgence of 
cases.
Methods: An analysis of surveillance data collected between July 2003 and June 2013 in the high malaria-transmis-
sion area of Ilha Josina Machel (Southern Mozambique) through a paediatric outpatient morbidity surveillance system 
was conducted to calculate hospital-based clinical malaria rates, slide-positivity rates, and minimum community-
based incidence rates (MCBIRs) and incidence rate ratios per malaria season in children younger than 15 years of age. 
Clinical malaria was defined as a fever ≥37.5 °C or a reported fever in the previous 24 h with a positive blood smear. 
Yearly mean age, geometric mean parasitaemia (GMP) and mean packed cell volume (PCV) were also described for all 
clinical malaria cases and compared between seasons using DID analysis or ANOVA tests.
Results: During the study period, the percentage of outpatient visits presenting with confirmed clinical malaria 
decreased from 51 % in the 2003–2004 season to 23 % in 2008–2009, followed by an increase back to 51 % in 2012–
2013. The yearly mean age of cases significantly increased from 2.9 (95 % CI 2.8–3.0) in 2003–2004 to 5.7 (95 % CI 
5.6–5.7) in 2012–2013, compared to non-malaria cases. An increase in mean PCV levels was also observed (p < 0.001), 
as well as in GMPs: from 5778 parasites/µL in 2002–2003 to 17,316 parasites/µL in 2012–2013 (p < 0.001) mainly driven 
by an increase in GMP in children older than 1 year of age. MCBIRs in infants decreased by 70 % (RR = 0.3, p < 0.001) 
between 2003–2004 and 2012–2013. Incidence diminished by a third among children 1- to 4-years between 2003 
and 2007, although such drop was unsustained as observed in 2012–2013 (RR = 1.0, 95 % CI 0.9–1.0). Finally, the inci-
dence among children 5–14 years was 3.8 (95 % CI 3.4–4.3) times higher in 2012–2013 compared to 2003–2004.
Conclusion: Since 2003, Ilha Josina Machel observed a significant reduction of clinical malaria cases which was 
followed by an upsurge, following the national trend. A shift in the age distribution towards older children was 
observed, indicating that the changes in the transmission intensity patterns resulted in a slower acquisition of the 
naturally acquired immunity to malaria in children.
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Background
As part of the Millennium Development Goals (MDGs) 
established by the United Nations in the year 2000, all 
malaria-endemic countries concentrated their efforts on 
reducing malaria incidence globally by 2015. In the last 
decade, 55 of the 106 countries with ongoing malaria 
transmission reached the target set in Objective 6 to 
reduce their malaria burden by 75  %. However, these 
countries contributed only to 6 % of the global estimated 
cases, suggesting that countries with the most affected 
populations, most of them from sub-Saharan Africa, have 
yet to reach this target [1].
Mozambique is part of the ten countries with the 
highest malaria endemicity in the world. Transmis-
sion intensity varies widely within the country, with 
high transmission intensity occurring in the north and 
a decreasing pattern observed as provinces are closer to 
the south of the country [2–4]. However, high transmis-
sion hotspots can still be found within wider low trans-
mission areas. Despite the increasing funding available 
for malaria control, Mozambique has experienced an 
increase in malaria incidence since 2007, according to 
national malaria surveillance data [1]. Although it is not 
clear what the main factors are driving these increasing 
malaria incidence trends, coverage of malaria control 
interventions is heterogeneous, and interventions are not 
delivered on a regular basis [2, 5]. Indoor residual spray-
ing (IRS) was first introduced in urban areas in 1994, 
whereby only ten districts in the country were selected. 
Insecticide-treated nets (ITN) deployment only started 
in 2004, primarily through donor funding. The south 
of Mozambique also took part in the Lubombo Spatial 
Development Initiative (LSDI), a tri-lateral initiative 
between the governments of Swaziland, South Africa and 
Mozambique that took place in the early 2000s, and offi-
cially finished its activities in 2011 [6, 7].
Monitoring malaria trends in the different areas of the 
country and characterizing changes in clinical presenta-
tion and age distribution of malaria cases during shifts 
in transmission is crucial to inform policy. High-quality, 
health facility-based surveillance data, despite the poten-
tial selection bias due to differences in health-seeking 
behaviour and accessibility, allow finely characterizing 
of clinical malaria epidemiology of an area over time, 
offering accurate and detailed information that can com-
plement information on trends observed through the 
national health management information system. Data 
from the Manhiça Health Research Centre (CISM) out-
patient paediatric morbidity surveillance system, oper-
ating in the southernmost province of Mozambique, 
identified heterogeneous epidemiological patterns within 
its study area. This study aims to analyse the epidemio-
logical trends of the outpatient clinical malaria cases 
from 2003 until 2013 in an area of high endemicity within 
the district if Manhiça, that experienced a drop in trans-
mission after IRS, ITNs, and artemisinin combination 
therapy (ACT), followed by a later resurgence of clinical 
cases. Evidence from this analysis may offer the National 
Malaria Control Programme (NMCP) additional insight 
on the clinical malaria profile that could be observed in 
other areas of the country that have experienced similar 
changes in malaria transmission.
Methods
Study design
This is an analysis of surveillance data collected through 
the Ilha Josina Machel health post (IJMHP) outpatient 
paediatric morbidity surveillance system. All visits in 
children younger than 15 years old from 1 July 2003 to 30 
June 2013 were included.
Study area and population
Ilha Josina Machel is a 188 km2 river island in the con-
fluences of the Incomati River, located about 50  km 
northeast of Manhiça village (Manhiça District, Maputo 
Province, Southern Mozambique) (Fig. 1). Approximately 
15,000 people live currently in the area, 40 % of the popu-
lation is under the age of 15 years, and 55 % are female. 
A third of the population is illiterate and the main occu-
pation consists of subsistence agriculture. Houses are 
simple, with walls typically made of cane with thatched 
or corrugated roofs. Basic and preventive care is pro-
vided at the IJMHP, including antenatal and delivery ser-
vices, but no admission facilities exist for sick patients, 
which are referred to Manhiça District Hospital in case 
of need. Additionally, as part of CISM’s study area, Ilha 
Josina Machel is covered by a demographic surveillance 
system (DSS), explained in detailed elsewhere [8], that 
identifies all residents within the catchment area and 
provides accurate yearly-updated estimates of commu-
nity denominators.
The region has two distinct seasons: a warm and rainy 
season from November to April, and a cooler and drier 
season the rest of the year. Rainfall trends varied through-
out the study period, with wetter rainy seasons between 
2002 and 2006, and slightly drier seasons between 2007 
and 2012 (Fig. 2). Malaria transmission is perennial with 
seasonality, mostly due to Plasmodium falciparum, with 
a few sporadic cases of Plasmodium malariae, and with 
Anopheles funestus as the main vector. Malaria trans-
mission was high in Ilha Josina Machel at the beginning 
of the study period. A cohort study to assess the P. fal-
ciparum re-infection rate was done in 2002, prior to the 
integration of Ilha Josina Machel in CISM’s health demo-
graphic surveillance system (HDSS). The study included 
288 children aged 6–18 months, who were followed up by 
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active detection of P. falciparum infection during 6 weeks 
after curative therapy with sulfadoxine-pyrimethamine 
(SP). Eighty-seven percent of participants had been re-
infected after 6 weeks, with an incidence rate of malaria 
infection of 4.35 episodes per child year at risk (95 % CI 
3.34–5.69) (unpublished data).
IRS started in 2004 and was implemented once every 
year, except for 2011. IRS was conducted using carba-
mates (lambda-cyhalothrin) at first, and dichloro-diphe-
nyl-trichloroethane (DDT) since December 2006. IRS 
coverage levels in the area are unknown, however cross-
sectional data from different surveys conducted by CISM 
since 2010 indicate that coverage of IRS in the previous 
12 months in Ilha Josina Machel was 88 % in 2010, 70 % 
in 2011 and 2012, and 57 % in 2013 (unpublished data). 
Focal distribution of long-lasting insecticide treated bed 
nets (LLINs) by the NMCP started in 2013, however they 
were available for purchase beforehand and were also 
distributed free of charge to pregnant women through 
antenatal clinics. CISM survey data show coverage of 
LLIN usage of 27  % in 2010, increasing approximately 
to 43 % between 2011 and 2013. Additionally, starting in 
2006, pregnant women attending antenatal clinic were 
administered intermittent preventive treatment (IPTp) 
with SP from the second term onwards.
During this study period (July 2003–June 2013), first-
line treatment for uncomplicated malaria was amodi-
aquine plus SP until September 2006, followed by ACT 
(initially artesunate plus SP and from 2009 onwards 
arthemether–lumefantrine, Coartem®).
Data collection
Since 2002, a passive case detection system was estab-
lished at the IJMHP to cover all outpatient visits of chil-
dren younger than 15  years, as part of the morbidity 
surveillance system run by CISM in all other health facili-
ties in the DSS area and described in detail elsewhere [9]. 
Briefly, a standardized questionnaire gathering personal 
and demographic data (including the DSS unique perma-
nent identification number, linking each patient to their 
geo-positioned household) as well as clinical informa-
tion regarding the current illness is completed for each 
child attending the outpatient clinic. A qualified clini-
cian records the physical signs and symptoms and their 
duration as referred by the child and/or accompanying 
guardian. A malaria blood smear (thick and thin films 
Fig. 1 Maps of Mozambique, Manhiça and Ilha Josina. Ilha Josina Machel forms part of the Manhiça district, located in the South Mozambique. Map 
a represents the health facility catchment areas covered by CISM’s Health and Demographic Surveillance System, with the households in  green and 
health facilities in  red. Map b shows the IJMHP catchment area
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on the same slide) is performed from a finger prick for 
all children with measured fever (axillary temperature 
≥37.5  °C), a history of fever in the preceding 24  h, or 
paleness, and blood is also collected into a microcapillary 
for packed cell volume (PCV) determinations. Final diag-
nosis/es using ICD-10 coding and treatment are recorded 
on the questionnaire by the clinician upon discharge or 
referral. Children fulfilling severity criteria are referred 
to the Manhiça District Hospital, where they are man-
aged accordingly. Malaria cases are treated according to 
national guidelines.
Thin and thick blood films were read to quantify para-
sitaemia in the CISM laboratory according to standard 
procedures. Blood films were air-dried, Giemsa-stained, 
and examined to quantify parasitaemia using a light 
microscope fitted with a 100× oil immersion lens and a 
10× eyepiece. Slides were declared negative only after 
counting 2000 leukocytes. Parasite numbers were con-
verted to a count/µL by assuming a standard leukocyte 
count of 8000/µL for blood slides collected until the end 
of June 2009 and using a fixed volume method [10, 11] 
from then onwards. Slides were first read at the health 
post using the ‘plus system’ [12] to guide case manage-
ment. If the parasitaemia result was missing, results from 
the ‘plus’-reading were used instead for the malaria case 
definition. PCV was measured using a micro-haematocrit 
centrifuge and a Hawksley reader (Hawksley & Sons Ltd, 
Lancing, UK) to assess levels of anaemia among cases.
Definitions
Clinical malaria was defined as the presence of fever 
(axillary temperature ≥37.5 °C) or history of fever in the 
preceding 24 h plus any asexual P. falciparum parasitae-
mia confirmed through blood smear microscopy. No age 
cut-off for the level of parasitaemia was used to increase 
the specificity of the definition, as this is the definition 
used at the outpatient clinic for all ages to diagnose and 
treat malaria.
The geometric mean parasite density (GMP) was cal-
culated as the mean of the log-transformed parasite den-
sities of clinical malaria cases per season. Mild anaemia 
was defined as a PCV between 25 and <33 %, moderate 
anaemia as a PCV of 15 to <25 % and severe anaemia as 
a PCV <15  %. Time was divided into ‘seasonal’ years (1 
July–30 June of the following year) in order to capture the 
full transmission season and be able to account for any 
fluctuations of rain patterns or other environmental fac-
tors between years.
Data management and analysis
Outpatient questionnaires were double-entered into a 
database using a program written in Fox Pro (Microsoft 
Fig. 2 Monthly and seasonal precipitation (mm) in Manhiça Dictrict (2003–2013). Monthly rainfall data for every year in the study were accessed 
from the Climate Hazards Group InfraRed Precipitation with Station dataset [33]. Data were withdrawn for the coordinates of the district of Manhiça 
to obtain robust rainfall estimates. Mean rainfall estimates were calculated for every malaria season and compared through the study period
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Corp, Seattle, WA, USA) at CISM. Statistical analyses 
were performed using Stata 13.1 (Stata Corp, College Sta-
tion, TX, USA).
The health post-based positive rate of clinical malaria 
(number of clinical malaria cases divided by total out-
patient visits to IJMHP) and slide positivity rates (num-
ber of positive blood smears divided by total number of 
blood smears collected) were calculated for every sea-
sonal year from 2003–2004 to 2012–2013.
Yearly mean age differences were calculated for clinical 
malaria cases and non-cases. A difference in difference 
(DID) analysis was conducted to compare the shifts in 
ages in time between malaria cases and non-cases. Mean 
age differences between years for malaria cases and non-
cases as well as the difference between those means were 
calculated using linear regressions with interaction terms 
between case category and season.
Yearly means of PCV and GMP by age group and their 
corresponding 95  % CI were also calculated to further 
explore the clinical and epidemiological trends of the dis-
ease through time. Analysis of variance (ANOVA) tests 
were conducted to compare means of normally distrib-
uted variables across seasonal years. PCV and GMPs 
were compared between age groups across the study 
period using multiple linear regressions and t tests. An 
increasing amount of outpatient visits with no PCV 
information was observed between 2007 and 2013 among 
clinical malaria cases, reaching 86 % of missing informa-
tion for PCV among the malaria cases observed between 
2012 and 2013. This was accounted for in the interpreta-
tion of results.
The DSS unique permanent identification number, 
which is recorded on the morbidity questionnaires when 
children attend the health post, was used to classify chil-
dren as residents/non-residents in the study area. Mini-
mum community-based incidence rates (MCBIRs) were 
calculated as the age-specific yearly number of malaria 
cases in children resident in Ilha Josina Machel who vis-
ited the outpatient clinic divided by the total child years 
at risk (CYAR) for that age group and year. CYARs were 
estimated from CISM’s DSS databases and children did 
not contribute to the numerator or denominator for an 
arbitrary period of 28 days after each episode of malaria. 
They were also excluded when they were outside the 
study area or after death. Clinical malaria incidence rate 
ratios (IRR) were calculated through Poisson regression 
to further explore the relative shift in clinical malaria 
incidence over the years within each age group. IRRs 
were also calculated for every age group separately, which 
permitted better characterization of the age-specific 
trends of the disease through time.
Results
A total of 70,698 visits were conducted at the outpatient 
clinic of the IJMHP between 1 July 2003 and 30 June 
2013. The number of annual visits steadily increased over 
the years, ranging from 5735 visits in 2003–2004 to 9851 
visits in 2012–2013 (Table  1). The mean age of all pae-
diatric visits steadily increased from 3.4 to 5  years dur-
ing the study period. Females represented 51  % of the 
outpatient visits, and 36  % of the cases presented with 
fever at time of visit every year. Malaria testing rates were 
constantly above 95  % for any case with fever or who 
reported to have fever in the previous 24 h.
More than half of all outpatient visits to the IJMHP 
between 2003 and 2006 were due to clinical malaria (51 % 
in the season of 2003–2004, 61 % in 2004–2005, and 57 % 
in 2005–2006). A sharp decline was observed between 
2007 and 2009, when less than a quarter (23  %) of all 
visits to the health facility were associated with malaria. 
From 2009 onwards, the number of clinical malaria cases 
increased steadily reaching again 51  % of all outpatient 
visits in 2012–2013. A similar trend was observed when 
analysing slide positivity rates (SPRs) (Fig. 3).
The mean age of clinical malaria cases presenting to the 
IJMHP steadily increased for every seasonal year, shift-
ing from 2.9 (SD 2.8) years in 2003–2004 to 5.7 (SD 3.5) 
year in 2012–2013. A different trend in mean age was 
observed among non-malaria cases, which was 3.9 (SD 
3.8) in 2003–21004 and decreased to a minimum of 3.2 
(SD 3.6) in 2006–2007, and increased steadily until 2012–
2013, when it was 4.4 (SD 3.9) (Fig. 4a). The DID analysis 
to compare age shifting patterns between malaria cases 
and non-cases showed a significantly larger increase in 
the mean age of patients with malaria than those with 
other pathologies. In general, the increase in malaria case 
ages was significantly higher for every year compared 
to the previous one except for 2007–2008 compared to 
2006–2007 and in between 2009 and 2012, where the 
increase in age was similar in both groups (Fig. 4b).
Out of all clinical malaria cases attending the IJMHP 
between 2003 and 2013, 46.8  % were mildly anaemic, 
13.4  % moderately anaemic and 0.7  % suffered from 
severe anaemia. A significant increase in the mean PCV 
among clinical malaria cases was observed, shifting from 
29.7 % (95 % CI 29.4–29.8) in 2003–2004, to 32.4 % (95 % 
CI 32.2–32.5, p  <  0.0001) in 2012–2013. Figure  5a pre-
sents the changes in PCV levels by age group throughout 
the study period. Infants had a lower PCV compared to 
1–4 and 5–14  year olds during the entire study period, 
with an increasing trend observed from 2003–2004 
(mean PCV 26.9  %, 95  % CI 26.5–27.4) to 2012–2013 
(mean PCV 30.2 %, 95 % CI 29.3–31.0).
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GMPs among clinical malaria cases experienced a 
steady and significant increase from 5778 parasites/
µL in 2002–2003 to 17,316 parasites/µL in 2012–2013 
(p  <  0.0001). Stratification by age group revealed that 
the overall shift in GMP was mainly driven by children 
older than 1  year who experienced infections of signifi-
cantly higher GMPs every year, with the steepest increase 
in children of 5–14 years old. On the other hand, GMPs 
of infants were similar over time, with a minor drop in 
2008–2009 (Fig. 5b).
The clinical malaria MCBIRs at the IJMHP experi-
enced a similar pattern to that observed for the pro-
portion of total visits with clinical malaria, starting 
with 667 cases per 1000 CYAR (95  % CI 639–697) in 
2003–2004, and decreasing to 206 cases per 1000 CYAR 
(95 % CI 191–221) in 2007–2008. A resurgence was later 
observed, reaching a total of 871 cases per 1000 CYAR 
(95  % CI 840–903) in 2012–2013, the zenith of the 
documented incidence in the area. Table 2 presents the 
clinical malaria MCBIRs and IRRs for every year of the 
study overall and by age group. Overall, children aged 
1–4  years experienced the highest number of incident 
clinical cases per 1000 CYAR at any point in time except 
for the first year, and children aged 5–14 years were the 
age group with the lowest incidence during the majority 
of the study period.
Table 1 Summary characteristics of clinical malaria cases attending the IJMHP between 2003 and 2013
SPR slide positivity rate, SD standard deviation, PCV packed cell volume, GMP geometric mean parasite density
a 86 % clinical malaria cases without PCV information
Season Total outpatient visits (%) SPR (%) Clinical malaria cases (%) Mean age (SD) Mean PCV (SD) GMP parasites per µL (SD)
03–04 5735 (8) 2886 (55) 2940 (51) 2.9 (2.8) 29.7 (5.8) 5778.3 (2.4)
04–05 5213 (7) 3122 (66) 3189 (61) 3.0 (2.7) 29.0 (5.5) 5846.6 (2.4)
05–06 5660 (8) 3123 (63) 3202 (57) 3.4 (3.0) 29.2 (5.7) 5214.3 (2.7)
06–07 6474 (9) 2778 (51) 2813 (43) 3.7 (3.1) 30.3 (5.4) 5692.9 (2.6)
07–08 6152 (9) 1288 (27) 1354 (22) 4.0 (3.1) 30.6 (5.5) 9443.9 (2.4)
08–09 7366 (10) 1646 (28) 1709 (23) 4.5 (3.2) 31.2 (5.1) 9443.1 (2.3)
09–10 7289 (10) 2049 (37) 2214 (30) 4.8 (3.2) 30.7 (5.2) 14,951.3 (2.6)
10–11 8291 (12) 3328 (47) 3336 (40) 5.3 (3.5) 31.1 (5.3) 15,788.5 (2.7)
11–12 8667 (12) 3354 (46) 3454 (40) 5.2 (3.4) 31.7 (5.3) 12,424.6 (2.7)
12–13 9851 (14) 4742 (56) 4986 (51) 5.7 (3.5) 32.4 (5.3)a 17,316.0 (2.5)
Total 70,698 (100) 28,316 (48) 29,197 (41) 4.3 (0.01) 30.5 (0.03) 10,189.9 (1469.0)
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Clinical malaria MCBIR trends varied significantly 
between different age groups throughout the study period. 
Incidence rates among infants consistently decreased to a 
third of the baseline levels by 2012–2013 (RR = 0.3, 95 % CI 
0.3–0.4, p < 0.001). One to 4 years olds also experienced a 
70 % reduction in the rate of clinical malaria cases between 
2003–2004 and 2007–2008 (RR  =  0.3, 95  % CI 0.3–0.3), 
although this was not maintained, and an increasing trend 
was later observed, reaching similar incidence levels to 
those of 2003–2004 in 2012–2013 (RR = 1.0, 95 % CI 0.9–
1.0). Finally, clinical malaria cases per 1000 CYAR among 
children older than 5 years remained unchanged between 
2002 and 2009, and experienced a significant increase until 
2013. By the last year of the study period, the incidence 
among children older than 5 years was 3.8 (95 % CI 3.4–
4.3) times higher than it was in 2003–2004 (Fig. 6).
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Discussion
This study aimed to characterize the epidemiologi-
cal trends of clinical malaria observed over a period 
of 10 years at a rural health centre in an area that had a 
high malaria transmission in 2002 and experienced a 
drop in malaria cases followed by a subsequent resur-
gence. IJMHP experienced a drop in clinical malaria 
cases between 2004–2005 and 2007–2008 followed by a 
resurgence of cases observed until the end of the study 
period in 2012–2013, detecting similar clinical malaria 
positive rates in 2012–2013 as that observed in 2003–
2004. These patterns resemble those observed in the rest 
of Mozambique, that despite increasing availability of 
funding for malaria control, has experienced an increase 
in the number of malaria cases reported to the NMCP 
since 2009 after a previous drop of cases [1]. Neverthe-
less, the national health management information system 
does not yet offer complete and accurate data that allows 
further characterization of the profile of malaria cases 
observed nationally, and data from Malaria Indicator 
Surveys are outdated (last performed in 2007).
In Ilha Josina Machel, a sharper increase of clinical 
cases was observed particularly among children on their 
first to fifth birthday between 2007 and 2013, as well 
as those between the ages of 5  and 15  years. Overall, a 
shift in the age distribution of the clinical malaria cases 
towards older children was observed particularly among 
malaria cases, indicative of an alteration in the transmis-
sion intensity patterns in the area [13] and a potential 
consequent impact on the naturally acquired immunity 
(NAI) of the population.
The current analysis does not allow for any assess-
ment of causality to evaluate which factors contributed 
to the decline and subsequent rise in transmission in 
the area. Rainfall patterns during the study period show 
a decrease in precipitation levels around the same years 
as malaria cases started to drop. This suggests that envi-
ronmental factors may have had a considerable effect on 
the epidemiology of malaria in the past decades. Further 
spatiotemporal studies in the area shall be conducted to 
more accurately measure the impact of climatic factors 
on malaria through time. However, it is plausible that 
the introduction of new malaria control measures also 
played an important role in the initial decline in trans-
mission. IRS was first deployed in Ilha Josina Machel in 
2004–2005, according to district records, which corre-
lates with the observed decrease in incidence between 
2006 and 2009. However, an increase in the number of 
clinical malaria cases was later observed, which could be 
associated with a decrease in the IRS effectiveness due 
to low coverage (as reported between 2010 and 2013), 
or lack of continuity of IRS activities (such as in 2011). 
In fact, malaria resurgences have been observed in a 
number of different settings across the world since the 
beginning of the twentieth century, most of which are 
attributed to weakening of malaria control programmes 
due to resource constraints, and a subsequent inability 
to ensure continuity of IRS in places where it had already 
been delivered [14].
The sudden drop in the number of clinical malaria 
cases between 2007 and 2009 possibly correlates with a 
consequent drop in transmission intensity of malaria in 
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the area at that time, considering that no changes were 
made in the reporting system and that malaria-testing 
rates remained constant throughout this period. The sig-
nificant shift in the age distribution of clinical malaria 
cases towards older children observed in IJMHP supports 
this hypothesis, as in lower transmission settings young 
children will be exposed to less infectious bites and will 
take longer to build up a naturally acquired immunity, 
with older children having a relatively high incidence of 
clinical malaria [15, 16]. Unpublished entomological data 
from Ilha Josina of 2006 and 2007 further support this 
drop in transmission, showing an entomological inocu-
lation rate (EIR) of 77 infectious bites per person during 
the dry season of 2006, to an EIR of 0.8 during the dry 
season of 2007. Similar shifts in the age distribution of 
clinical malaria cases as a function of transmission inten-
sity have been extensively reported in the past in other 
sub-Saharan African countries [17–21].
The low-transmission period between 2007 and 2009 was 
followed by an immediate increase in the incidence of clini-
cal malaria cases, particularly among 1–4  years olds and 
later also in the 5–14 years olds. During the lower malaria 
transmission period there was a decrease in the exposure to 
parasites in children (evident in the incidence rates among 
infants since 2007), delaying the acquisition of NAI in 
younger children and diminishing the premunition in older 
children that had already developed some NAI during the 
previous years [22]. Several studies, conducted to evalu-
ate this question through actively interrupting exposure to 
the parasite using chemoprophylaxis at a very young age, 
have reported a similar rebound effect in the incidence of 
clinical malaria cases among children in the treatment arm, 
up to 1  years after treatment [15, 23–25]. The biological 
mechanisms driving the acquisition of NAI are still not well 
understood; however, evidence from mathematical models 
[26, 27] and immunological studies [28, 29] clearly identify 
age, exposure to the parasite and transmission intensity as 
important factors involved in this process.
The lower increase in the incidence rate of clinical 
malaria cases among infants may be partly explained by 
a drop in transmission; however other interventions such 
as the introduction of vector control activities targeting 
pregnant women and infants could have also contrib-
uted to an increased protection against parasite exposure 
among this age group.
The age-specific GMP trends observed in this study, 
with significant increases in parasitaemia in children older 
than 1  year after 2007 also show a slower acquisition of 
NAI with age and a lower ‘anti-parasite’ immunity [22]. 
In addition, the increase of mean PCV with age despite a 
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Fig. 6 Yearly incidence rates (in 1000 per CYAR) by age group, observed at the IJMHP. Yearly MCBIRs in 1000 per CYAR were calculated to assess 
clinical malaria incidence observed in infants (blue), 1–4 years olds (red), and 5–14 years olds (green), at the IJMHP between 2003 and 2013. CYARs 
were obtained from CISM’s DSS, which is updated on a yearly basis
Page 11 of 12Galatas et al. Malar J  (2016) 15:444 
raise in parasitaemia could possibly be a reflection of lower 
chronic infections or lower number of episodes per year, 
which cause less anaemia and does not allow the anti-par-
asite immunity to develop fast, resulting in the delay in the 
rate of NAI and the observed high parasitaemic infections.
Insecticide resistance may also be a contributing fac-
tor to the observed resurgence in the number of clinical 
malaria cases in the area. Mosquito resistance to pyre-
throids was first reported in 2011 in a nearby sugar cane 
plantation of Maragra in the district of Manhiça [30]. 
Another study in a Northern province also reported 
wide resistance to pyrethroids and carbamates in 2007 
[31]. Entomological data from CISM further supports 
these findings revealing less than 9.6  % sensitivity to 
pyrethroids among the A. funestus population of the 
district of Manhiça [32]. Insecticide resistance to pyre-
throids has serious implications regarding the likely 
impact of LLINs towards reducing malaria transmission 
in the area, which since 2011 may have contributed to 
the increasing malaria incidence trends in the area.
The estimates obtained from this analysis are subject 
to a series of limitations. First, access to health care may 
have increased through the years. This could have caused 
an underestimation of the malaria burden in the area on 
the first years of the study, and a consequent overestima-
tion of IRRs when comparing rates across years. Second, 
IJMHP data are also susceptible to the Hawthorne effect 
[16], as the presence of CISM, its impact on case man-
agement as well as research studies conducted, may affect 
the overall epidemiology of malaria in the study area of 
Manhiça. Particularly, Ilha Josina Machel was included as 
one of the sites where the RTS,S vaccine trials took place 
between 2002 and 2008. This analysis was also affected by 
missing data of PCV particularly in the last years of the 
study, which may have affected the estimates of severe 
and mild anaemia cases during these years.
Additionally, this study aims to provide a tempo-
ral description of the clinical malaria epidemiology in 
a health facility. Therefore, it did not conduct any soci-
odemographic or environmental risk factor analysis, 
which would enrich the interpretations withdrawn from 
the results obtained from this particular assessment. 
Separate studies should be conducted to respond to the 
hypothesis raised in this study, identify the main driv-
ers of malaria transmission in the area and determine 
the social factors that may put a resident in the area at a 
higher risk of malaria than others.
Conclusion
This study shows a reduction in the clinical malaria 
incidence in a small area of initially high transmission 
in Southern Mozambique, and a subsequent resur-
gence of cases. Evidence from this study indicates that 
efforts to control malaria and reduce transmission 
need to be sustained over time in order to guarantee 
gains in the long term. Malaria control programmes 
with limited resources, such as the one in Mozam-
bique, should consider malaria control interventions 
that ensure sustainability and target the most vulner-
able populations, particularly infants and children 
under 5, at all times. Considering the costs and opera-
tional difficulty of this task, NMCPs should consider 
investing in innovative strategies to drastically inter-
rupt transmission and eliminate the parasite reser-
voir from communities in a short period of time, and 
subsequently concentrate efforts to manage and elimi-
nate remaining foci of transmission and imported 
infections.
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